CSF2 and neoplasm: We subsequently combined the Anchored GM-CSF vaccine with PD-1 and Tim-3 blockade in an established subcutaneous PCa model and found that this combination therapy could significantly suppress tumor growth and increase the tumor regression rate in 62.5% of the mice.